Egetis Therapeutics AB (publ) (LON:0ABW)
London
· Delayed Price · Currency is GBP · Price in SEK 4.875
-0.275 (-5.34%)
At close: Feb 21, 2025
Egetis Therapeutics AB Market Cap
Egetis Therapeutics AB has a market cap or net worth of 130.30 million as of February 21, 2025. Its market cap has increased by 5.80% in one year.
Market Cap
130.30M
Enterprise Value
128.98M
Revenue
4.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.88
Market Cap Chart
Since April 7, 2011, Egetis Therapeutics AB's market cap has increased from 21.81M to 130.30M, an increase of 497.37%. That is a compound annual growth rate of 13.74%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 179.71B |
| Shell | 161.28B |
| HSBC Holdings | 157.51B |
| Unilever | 110.61B |
| Rio Tinto Group | 86.77B |
| RELX PLC | 72.31B |
| BP p.l.c. | 70.06B |
| British American Tobacco p.l.c. | 65.18B |